These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1976330)

  • 1. Phosphatidylinositol kinase and cell transformation.
    Takenawa T; Kato M; Yamakawa A
    Adv Second Messenger Phosphoprotein Res; 1990; 24():317-22. PubMed ID: 1976330
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormonal regulation of phosphatidylcholine breakdown.
    Exton JH
    Adv Second Messenger Phosphoprotein Res; 1990; 24():152-7. PubMed ID: 1976328
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutational analysis of the role of the carboxy-terminal region of the v-erbB protein in erythroid cell transformation.
    Lee EB; Beug H; Hayman MJ
    Oncogene; 1993 May; 8(5):1317-27. PubMed ID: 8097581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of inositol trisphosphate from diacylglycerol production in Rous sarcoma virus-transformed fibroblasts.
    Martins TJ; Sugimoto Y; Erikson RL
    J Cell Biol; 1989 Feb; 108(2):683-91. PubMed ID: 2537320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyoma virus middle tumor antigen stimulates membrane-associated protein kinase C at lower levels than required for phosphatidylinositol kinase activation and neoplastic transformation.
    Marcellus R; Whitfield JF; Raptis L
    Oncogene; 1991 Jun; 6(6):1037-40. PubMed ID: 1648699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The oncogenic protein p60v-src has competence activity but does not activate phosphatidylinositol turnover or protein kinase C in Balb/c 3T3 cells.
    Han JW; Gaut J; Burstein E; Sadowski H; Young D; Macara IG
    Oncogene; 1990 Apr; 5(4):467-74. PubMed ID: 2158036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of LPA-mediated calcium signaling and inositol polyphosphate production in rat-1 fibroblasts transformed by the v-src oncogene.
    Glazier AT; Blackmore PF; Nolan RD; Wasilenko WJ
    Biochem Biophys Res Commun; 1998 Apr; 245(2):607-12. PubMed ID: 9571202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The messenger phosphatidylinositol and antimanic drug-antidepressants].
    Morishita S
    Yakubutsu Seishin Kodo; 1991 Jun; 11(3):177-85. PubMed ID: 1663305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
    Tian M; Martin GS
    Oncogene; 1996 Feb; 12(4):727-34. PubMed ID: 8632894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproliferative effects of heparin on normal and transformed NIH/3T3 fibroblasts.
    Cavari S; Ruggiero M; Vannucchi S
    Cell Biol Int; 1993 Aug; 17(8):781-6. PubMed ID: 8106075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein phosphorylation and cell transformation.
    Hanafusa H
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Feb; 24(1):1-9. PubMed ID: 1718667
    [No Abstract]   [Full Text] [Related]  

  • 12. New oncogene targets?
    Marx JL
    Science; 1984 Apr; 224(4646):272. PubMed ID: 6324341
    [No Abstract]   [Full Text] [Related]  

  • 13. Herbimycin A inhibits the association of p60v-src with the cytoskeletal structure and with phosphatidylinositol 3' kinase.
    Hamaguchi M; Xiao H; Uehara Y; Ohnishi Y; Nagai Y
    Oncogene; 1993 Mar; 8(3):559-64. PubMed ID: 8382356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-independent oncogenic transformation by the EGF receptor requires kinase domain catalytic activity.
    Danielsen AJ; Maihle NJ
    Exp Cell Res; 2002 Apr; 275(1):9-16. PubMed ID: 11925101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly conserved amino acids in the SH2 and catalytic domains of v-src are altered in naturally occurring, transformation-defective alleles.
    Verderame MF; Varmus HE
    Oncogene; 1994 Jan; 9(1):175-82. PubMed ID: 8302576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phosphatidylinositol-3 kinase, a candidate for a second messenger producer].
    Fukui Y
    Tanpakushitsu Kakusan Koso; 1991 Oct; 36(12):1901-10. PubMed ID: 1665237
    [No Abstract]   [Full Text] [Related]  

  • 17. Clustered cysteine residues in the kinase domain of v-Src: critical role for protein stability, cell transformation and sensitivity to herbimycin A.
    Senga T; Miyazaki K; Machida K; Iwata H; Matsuda S; Nakashima I; Hamaguchi M
    Oncogene; 2000 Jan; 19(2):273-9. PubMed ID: 10645006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. v-Src-induced degradation of focal adhesion kinase during morphological transformation of chicken embryo fibroblasts.
    Fincham VJ; Wyke JA; Frame MC
    Oncogene; 1995 Jun; 10(11):2247-52. PubMed ID: 7784071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A newly isolated avian sarcoma virus, ASV-1, carries the crk oncogene.
    Tsuchie H; Chang CH; Yoshida M; Vogt PK
    Oncogene; 1989 Nov; 4(11):1281-4. PubMed ID: 2554234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitogenesis by v-Src: fluctuations throughout G1 of classical immediate early AP-1 and mitogen-activated protein kinase responses that parallel the need for the oncoprotein.
    Wyke AW; Frame MC; Gillespie DA; Chudleigh A; Wyke JA
    Cell Growth Differ; 1995 Oct; 6(10):1225-34. PubMed ID: 8845299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.